Pharmacists enhance oncology care by guiding younger patients through precision diagnostics like ctDNA MRD testing, driving innovation in cancer treatment.
Thomas P. Slavin Jr., MD, MBA, FACMGG, DABMD
Advertisement
Articles by Thomas P. Slavin Jr., MD, MBA, FACMGG, DABMD
Advertisement
Latest Updated Articles
Advancing Precision Oncology: Perspectives for Pharmacists on MRD Testing and Diagnostic InnovationPublished: December 13th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
2
Study Finds No Evidence That Hormone Therapy Use Affects Dementia Risk in Postmenopausal Women
3
FDA Expanded Approval of Imiglucerase Expands Treatment Options for Type 3 Gaucher Disease
4
New AHA Scientific Statement Notes Socioeconomic, Structural Barriers to Addressing Obesity
5